SCHEMBL7495170

SCHEMBL7495170

CCOC(=O)c1c(C)nc2c(NCc3cccc(C)c3C)cccn12

nearest known ligand 0.66

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SMN1; SMN2 Q16637 4/20 0.66
CYP1A2 P05177 4/20 0.53
CYP2C9 P11712 4/20 0.53
CYP2C19 P33261 4/20 0.53
CYP3A4 P08684 3/20 0.53
CYP2D6 P10635 3/20 0.53
MEN1 O00255 3/20 0.52
KMT2A Q03164 3/20 0.52
MAPK1 P28482 4/20 0.51
MAPT P10636 4/20 0.51
TP53 P04637 3/20 0.51
HCRTR1 O43613 1/20 0.51
ALOX15 P16050 1/20 0.51
RAB9A P51151 1/20 0.51
ALDH1A1 P00352 4/20 0.46
HSD17B10 Q99714 2/20 0.46
KDM4E B2RXH2 1/20 0.46
HPGD P15428 1/20 0.46
PSEN1 P49768 1/20 0.44
PSEN2 P49810 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6433684 0.88 SMN1; SMN2 (0.70) SMN1; SMN2CYP1A2CYP2C9CYP2C19CYP3A4
SCHEMBL6356136 0.85 SMN1; SMN2 (0.60) SMN1; SMN2CYP1A2CYP2C9CYP2C19CYP3A4
SCHEMBL7496961 0.80 SMN1; SMN2 (0.61) SMN1; SMN2CYP1A2CYP2C9CYP2C19CYP3A4
SCHEMBL7012733 0.79 SMN1; SMN2 (0.56) SMN1; SMN2CYP1A2CYP2C9CYP2C19CYP3A4
SCHEMBL6354022 0.76 CYP3A4 (0.52) SMN1; SMN2CYP1A2CYP2C9CYP2C19CYP3A4
SCHEMBL7494111 0.76 CYP3A4 (0.62) SMN1; SMN2CYP1A2CYP2C9CYP2C19CYP3A4
SCHEMBL6350950 0.75 SMN1; SMN2 (0.54) SMN1; SMN2CYP1A2CYP2C9CYP2C19CYP3A4
SCHEMBL6356150 0.75 CYP3A4 (0.68) SMN1; SMN2CYP1A2CYP2C9CYP2C19CYP3A4
SCHEMBL7502575 0.75 SMN1; SMN2 (0.78) SMN1; SMN2CYP1A2CYP2C9CYP2C19CYP3A4
SCHEMBL20579804 0.75 SMN1; SMN2 (0.78) SMN1; SMN2CYP1A2CYP2C9CYP2C19CYP3A4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0971920-B1 COMPOUNDS FOR INHIBITION OF GASTRIC ACID SECRETION ASTRAZENECA AB (SE) 2002-06-05 EP disclosed
US-6265415-B1 ANTIULCER AGENT ASTRAZENECA AB (SE) 2001-07-24 US disclosed
EP-0971920-A1 COMPOUNDS FOR INHIBITION OF GASTRIC ACID SECRETION Astra Aktiebolag (SE) 2000-01-19 EP disclosed
WO-1998037080-A1 COMPOUNDS FOR INHIBITION OF GASTRIC ACID SECRETION ASTRA AKTIEBOLAG (SE) 1998-08-27 WO disclosed